Alloy Therapeutics Raises $42 Million Series D Financing To Accelerate Discovery Technology Development Across Biologic Modalities
Amount Raised
$42 Million
Round Type
Series D
BostonBiotechnologyInvestors
Description
Alloy Therapeutics, a biotechnology ecosystem company, has closed $42 million in Series D financing led by its existing investors 8VC and Mubadala Capital and joined by return investors Thiel Capital, Presight Capital, Founders Fund, and other unnamed family offices and sovereign wealth funds. Alloy will use proceeds from the Series D financing to further support the drug discovery community with new pre-competitive drug discovery technologies in new biologic modalities and new partnership models designed to fuel innovation.
Quick answer
Alloy Therapeutics raised $42 Million in a Series D round, dated October 3, 2022. Investors: Thiel Capital. Alloy Therapeutics is based in Boston, Massachusetts, United States.
- How much did Alloy Therapeutics raise?
- Alloy Therapeutics raised $42 Million in a Series D round on October 3, 2022.
- Who invested in Alloy Therapeutics?
- Thiel Capital is named as investors in this round.
- What does Alloy Therapeutics do?
- Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together.
- Where is Alloy Therapeutics based and how big is it?
- Alloy Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 119 employees.
- Who are the decision-makers at Alloy Therapeutics?
- Fundz holds 2 contacts at Alloy Therapeutics, including the Senior Vice President - Antibody Discovery Services. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alloy Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Qntm Labs raised an undisclosed amount (Series A) on November 17, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Sonomotion Inc. raised $12M (Series C) on November 17, 2022.
- Cue Biopharma raised an undisclosed amount (Funding Round) on November 17, 2022.
- Theralase® Technologies raised an undisclosed amount (Post-IPO Equity) on November 17, 2022.
- Tellus Therapeutics raised $16M on November 17, 2022.
Who to call at Alloy Therapeutics, and when
A new round usually means Alloy Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alloy Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alloy Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alloy Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alloy Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alloy Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.